Status: Recruiting
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
This study is designed to estimate the efficacy and toxicity of familial HLA mismatched bone marrow transplants in patients with non-malignant disease who are less than 21 years of age and could benefit from the procedure.
Participants needed: 29
Trial details
Phase: Phase 1, Phase 2Age: 1-21Biological sex: AllType: InterventionalSponsor: Washington University School of MedicineUpdated: May 29, 2026Locations: 4
Eligibility criteria
Nonmalignant disorder requiring bone marrow transplant including bone marrow fai... [+17]
Patients who have an HLA-identical sibling who is able and willing to donate bon... [+7]